In The News
Merivale reaches new class action settlement after first deal scrapped
Judge questions Dentons’ claim of ignorance of alleged search for dirt
EnergyAustralia hit with $14M penalty for misleading consumers about prices
AI next big issue in construction, says new Colin Biggers & Paisley partner
Class action over $85M Clydesdale development loses injunction bid
Biotech files new patent suit against Samsung Bioepis over Crohnā€™s drug
ACCC clears Lendlease’s $1.3B property deal with Stockland
Full Court confirms FOI requests survive ministry reshuffles
Appeal filed to set aside $112M Robodebt class action settlement
Dentons chair says he ‘abhors’ offensive statements in anti-vax report
Please login to bookmarkClose

South Korean biotech ToolGen has won court approval to patent its genome editing technology CRISPR, after an earlier bid to protect its IP found the revolutionary technology was not patentable.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au